The drugstore chain made a blood-testing deal without fully validating the startup’s technology, worrying that Elizabeth Holmes might balk if Walgreens pushed too hard.
WSJ.com: Health, Wall Street Journal: Business: Health
Wed, 05/25/2016 - 5:28pm